午夜不卡av免费-国产在线播-亚洲精品三-亚洲一区av在线观看-香蕉视频免费在线观看-日本丰满大乳免费xxxx-天天躁夜夜躁狠狠喷水-制服 丝袜 有码 无码 中文-桃色视频.m3u8-视频一区二区欧美-亚洲第一夜页-黄色一级视屏-正在播放国产对白孕妇作爱-亚洲成人7777-日韩aⅴ在线观看-国产精品bbwbbwbbw在线-亚洲激情啪啪-ā片在线观看免费看无码-av无码爆乳护士在线播放-国产不卡视频一区二区三区

Welcome to Linuo Group!HomeBusiness License
  • CN

  • WeChat

  • Mobile Site

  • Search

力諾產業

Shandong Keyuan Pharmaceutical Co., Ltd.

2017.09.19

Founded in 2004, Shandong Keyuan Pharmaceutical Co., Ltd. is the core member of Linuo Healthcare Industry. It is a high-tech company dedicated to the R&D, manufacture and sales of APIs. Its portfolio covers anti-diabetic agents, cardiovascular agents and anesthetics. Keyuan has established strategic partnership with many renowned international companies.  
The company consistently upholds the entrepreneurship and practical working style. With the accumulative industrial strength and the technology-guided and people-oriented business principle, the company has gradually become the backbone of Shandong synthetic API industry.  
The company produces gliclazide, metformin hydrochloride, isosorbide mononitrate, isosorbide dinitrate, isoclurance, ropivacaine hydrochloride and clarithromycin lactobionate.
Main accreditations: gliclazide, isosorbide monoitrate mixed powder and other products have obtained the accreditation of CEP. PLNS has obtained the accreditation of FDA.
In March 2016, Keyuan was listed on NEEQ. NEEQ varies the choice of investment and expands the withdrawal of venture investment institutions. Being listed on NEEQ provides more financing channels for the company, expanding the financing platform, and make the financing more flexible, which lays an increasingly solid foundation for the further development of the company and strengthens its international competitiveness. Keyuan will make itself a larger and stronger company with the help of the capital market.
Keyuan upholds the motto of Serving the country with industry and striving for excellence and is devoted to establishing the largest production base of anti-diabetic agents, cardiovascular agents and anesthetics for the benefit of the patients.